Pediatric Hematology and Oncology

Papers
(The TQCC of Pediatric Hematology and Oncology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Environmental health disparities in pediatric cancer: a report from the Fourth Symposium on Childhood Cancer Health Disparities12
The time to diagnosis and survival in children with solid tumors and lymphoma: results from a single center in Turkey10
MicroRNA-199a deficiency relates to higher bone marrow blasts, poor risk stratification and worse prognostication in pediatric acute myeloid leukemia patients10
Aceruloplasminemia presenting with microcytic anemia in a Turkish boy due to a novel pathogenic variant9
A brief review of the current knowledge on environmental toxicants and risk of pediatric cancers8
The pre-surgical factors that determine the decision to proceed to resection in children diagnosed with high-risk neuroblastoma in a resource limited setting8
The expression of PHOX2B in bone marrow and peripheral blood predicts adverse clinical outcome in non-high-risk neuroblastoma8
The role of pediatric oncologist in prenatal diagnosis: A 10-year retrospective study at Assistance Publique Hôpitaux de Marseille (AP-HM)8
Rivaroxaban for Management of Venous Thromboembolism in Pediatric Nephrotic Syndrome; a Case Report and Review of Literature7
GATA2-related myeloid neoplasms in pediatrics: where do we stand?7
Prognostic significance of survivin expression in pediatric ewing sarcoma7
Outcome of pediatric germ cell tumor with comparison of carboplatin and cisplatin based regimens: A 10-year analysis7
Prevalence of the BRAF V600E mutation in Greek adults with Langerhans cell histiocytosis7
Myelofibrosis associated with immune cytopenia in an infant: a diagnostic and therapeutic challenge6
Factors Related to the Quality of Life in Children with Transfusion-Dependent Thalassemia6
Hepatic veno-occlusive disease with asparaginase products: a review of cases reported to the FDA adverse event reporting system and published in the literature6
Tyrosine kinase inhibitor treatment and long-term follow-up for metastatic malignant struma ovarii6
Response to neoadjuvant selpercatinib in a pediatric patient with advanced papillary thyroid carcinoma: a case report6
Clinical practice guidelines on management of infantile hemangioma: a systematic quality appraisal using the AGREE II instrument5
Temporal trends and unbalanced distribution, in pediatric cutaneous melanoma in 204 countries and territories, 1990-20195
The clinicopathological profile and value of multidisciplinary management of pediatric brain tumors in a low-income setting5
Effect of platelet count and platelet transfusion on fever duration in patients with febrile neutropenia5
Comparative analysis of a novel next-generation sequencing-based IGH clonality assay for measurable residual disease detection in pediatric B-cell acute lymphoblastic leukemia patients5
Global caregiver concerns of SARS-CoV-2 vaccination in children with cancer: a cross-sectional mixed-methods study5
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children’s oncology group report5
Treatment outcomes in patients with Ewing sarcoma of the spine in a resource-challenged setting: 17-year experience from a single center in India5
Gross motor disorders in pediatric patients with acute lymphoblastic leukemia and survivors: A systematic review5
Late effects care for childhood brain Tumor Survivors: A Quality-Improvement Initiative4
The relationship between circulating tumor cells in peripheral blood and clinical characteristics of pediatric neuroblastoma and prognostic evaluation4
Co-transplantation of umbilical cord mesenchymal stem cells and peripheral blood stem cells in children and adolescents with refractory or relapsed severe aplastic anemia4
Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study4
Impact of minimal residual disease on relapse in childhood acute lymphoblastic leukemia: Lessons learnt from a tertiary cancer center in India4
Methotrexate concentrations and associated variability factors in high dose therapy of children with acute lymphoblastic leukemia and non-Hodgkin lymphoma4
Acute myeloid leukemia in a child with familial platelet disorder and a cryptic runx1 intragenic deletion4
Assessment of plasminogen activator inhibitor-1(PAI1) and thrombin activitable fibrinolysis inhibitor (TAFI) in Egyptian children with hemophilia A4
Advancing the Care of Pediatric Rare Solid Tumors: A virtual rare tumor board4
How to recognize inborn errors of immunity in a child presenting with a malignancy: guidelines for the pediatric hemato-oncologist4
MiR-143-3p Inhibits Cell Proliferation in Pedatric Acute Myeloid Leukemia via Inhibition of KAT6A4
Clinical profile and outcome of children with anaplastic large cell lymphoma treated with short-course chemotherapy – ten years experience from a tertiary care center in a LMIC4
Early Decline of Neuron-Specific Enolase during Neuroblastoma Chemotherapy is a Predictive Factor of Clinical Outcome3
The Onset of Puberty Presents Unique Management Issues in Penile Chronic Graft-versus-Host Disease Requiring Circumcision in Male Pediatric Patients3
Diverse outcomes in extra-cranial rhabdoid tumors: A single institute experience3
Clinical characteristics and successful treatment outcomes of children and adolescents with Kaposi sarcoma in Southwestern Tanzania3
Letter to editor regarding “Clinical practice guidelines on management of infantile hemangioma: a systematic quality appraisal using the AGREE II instrument”3
Impact of restrictive measures due to the Covid-19 pandemic on the incidence of immune thrombocytopenia in children: an Italian single center experience3
Prevalence and Risk Factors for Pulmonary Embolism in Pediatric Sickle Cell Disease: A National Administrative Database Study3
Pediatric AML: state of the Art and Future Directions3
Psychosocial and mental profile of children with sickle cell disease and their caregivers3
Haploidentical hematopoietic cell transplant for severe aplastic anemia in children with carbapenem-resistant enterocolitis3
Changes in anthropometrical status and body composition in children with cancer during initial chemotherapy3
Substrate oxidation during exercise in childhood acute lymphoblastic leukemia survivors3
Safety and Tolerability of a 3-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients: Results of an Open-Label, Single-Arm Phase 4 Trial3
The efficacy and safety of midazolam with fentanyl versus midazolam with ketamine for bedside invasive procedural sedation in pediatric oncology patients: A randomized, double-blinded, crossover trial3
Alpelisib in pediatric PIK3CA- and TIE-2–mutant vascular anomalies: a case series on safety, efficacy, and drug exposure2
Clonal hematopoiesis of indeterminate potential is rare in pediatric patients undergoing autologous stem cell transplantation2
Reducing empiric antibiotic administration in pediatric oncology patients with non-neutropenic fever: a single-center quality improvement initiative2
Hypothyroidism in children with Hb E/β-thalassemia compared between those who received regular transfusion and those who underwent hematopoietic stem cell transplantation2
Temporal trends in pediatric cancer mortality: rare cancers lag behind more common cancers2
A case control analysis of pattern and risk factors for pulmonary dysfunction amongst childhood cancer survivors: a single centre study from a low-middle income setting2
Characterizing age-related differences in Hodgkin lymphoma in children, adolescents and young adults2
Interaction between CASP8AP2 and ZEB2-CtBP2 Regulates the Expression of LEF12
Gonadal health in recipients of nonmyeloablative hematopoietic stem cell transplantation in children and adolescents with sickle cell disease2
Specific cytokine patterns in Epstein-Barr virusassociated hemophagocytic lymphohistiocytosis compared to Kawasaki disease in children2
Clinical and genetic characteristics of hemoglobin H disease in Iran2
Noncompliance of pediatric cancer patients with chemotherapy: A single-center experience in a lower-middle income country2
Can N-acetylcysteine reduce red blood cell transfusion burden in patients with transfusion-dependent β-thalassemia?2
Allogeneic hematopoietic stem cell transplantation in an adolescent with Prader-Willi syndrome – unique considerations2
Treatment of Langerhans cell histiocytosis with subcutaneous cytarabine2
Hospital acquired venous thromboembolism in children with sickle cell disease2
Access to Methotrexate Monitoring in Latin America: A Multicountry Survey of Supportive Care Capacity2
Evaluation of pharmacological efficacy and safety of hydroxyurea in sickle cell disease: Study of a pediatric cohort from Chhattisgarh, India2
Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults wi2
Potential role of serum vitamin D as a risk factor in pediatric acute lymphoblastic leukemia2
Levofloxacin prophylaxis in pediatric oncology and hematopoietic stem cell transplantation: a literature review2
Sickle-Cell Disease and Stroke: Quality of Life of Patients in a Chronic Transfusion Regimen from the Caregivers’ Perspective2
Hematopoietic Stem Cell Transplantation in Children with Sickle Cell Disease and Thalassemia Major: A National Database Study2
Outcome and complications of pediatric acute promyelocytic leukemia in Bangladesh2
Early mortality continues to be a barrier to excellent survival in childhood acute promyelocytic leukemia: a retrospective study of 62 patients spanning 17 years2
PASTEC - a prospective, single-center, randomized, cross-over trial of pure physical versus physical plus attentional training in children with cancer2
Thalassemia patients in transfussion dependent period and after hematopoietic stem cell transplantation: how are the psychiatric status and life quality of these patients?2
The effects of NUDT15 and TPMT variants on mercaptopurine treatment in Vietnamese pediatric acute lymphoblastic leukemia patients2
Consensus survey on the management of children with chemotherapy-induced febrile neutropenia and at low risk of severe infection2
Quantitative analysis of IKZF1 gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia: higher levels are associated with a poorer prognosis2
Vitamin D deficiency in a pediatric population with sickle cell disease2
German physicians’ perceptions and views on complementary medicine in pediatric oncology: a qualitative study2
Application of microRNAs in the diagnosis and monitoring of pediatric germ cell tumors: Kazakh experience2
Near-Haploid B-Cell Acute Lymphoblastic Leukemia in a Patient with Rubinstein-Taybi Syndrome2
Assessment of depression in children and adolescents with sickle cell anemia in a low-resource setting: a comparative study2
Development and field testing of a neuro psychomotor multidimensional grid for the assessment of children with cns tumor2
An unusual case of primary cold agglutinin-associated lymphoproliferative disease in an adolescent female2
Vincristine-induced neurotoxicity in pediatric patients with rhabdomyosarcoma: A retrospective analysis of clinical features and outcome2
0.22810792922974